Introduction
treatment of glomerular diseases for nearly 40 years and have shown variable success in patients with IgAN. What most disturbs us as physicians is the feeling of In a retrospective study Kobayashi et al. [4] reported impotence when confronted with an important disease favourable results in patients with heavy proteinuria without established therapeutic approach. Thus it is after steroid treatment for 18 months compared to not surprising that nephrologists were disappointed treatment with non-steroidal anti-inflammatory drugs because evidenced-based treatment was not available or anticoagulants. During a 10-year follow-up of 46 for the commonest glomerulonephritis world-wide, i.e.
IgAN patients with normal renal function and moderIgA nephropathy (IgAN ). This was particularly frusate proteinuria (1-2 g/day), renal survival was signitrating because, despite previous opinion to the conficantly better in the group treated with steroids (100% trary, IgAN is often progressive. Nearly 25-50% of adult patients need dialysis or renal transplantation vs 84% at 5 years and 80% vs 34% at 10 years) [5] . within 10-25 years [1, 2] and the outcome in children The results of randomized trials are more equivocal is also less than encouraging. Yoshikawa et al. [3] [6] [7] [8] . Preliminary data of a multicentre prospective reported that 6% and 11% of 241 children with IgAN trial in IgAN patients with moderate proteinuria do developed chronic renal failure (CRF ) by 10 and 15 not support a favourable effect of steroids in a dose years respectively from the onset of the disease. It is of 60 mg/day tapered by 10 mg every 3 months to important to keep in mind that most patients with 10 mg/day over 24 months. Only modest reduction in IgAN develop end-stage renal disease ( ESRD) in their proteinuria and no effect on renal function were middle age. This represents not only an important observed [6 ] . Short-term (12 weeks) therapy with problem for the patient, but also a significant social prednisone was also found to be ineffective in 20 and economic burden for society as a whole. The children [7] . More encouraging are the results of interest in finding out effective interventions is reflected treatment with prednisone for 2 years in 13 children. by the long list of therapeutic approaches that have Significant improvement of urinary findings (both probeen suggested so far. However, these therapies have teinuria and haematuria) were noted in comparison been mainly tested in a relatively small number of with a historical group [8] . Renal biopsy performed at patients and none of them has been proved to be the end of treatment revealed a significant decrease in actually effective in the long term. The problem is the activity score, without significant increase in the further complicated by the fact that the course of chronicity score [8] . Taken together, these studies IgAN is extremely variable [1, 2] . Patients display suggest that a short course of steroids does not offer very different rates of progression towards ESRD. any particular benefit, whereas longer courses may Strangely, some patients in whom renal function is favourably alter the evolution of IgAN. One would impaired at the time of diagnosis do not progress at anticipate, however, that a longer course carries a all even after decades. This makes it very difficult to greater risk of side effects. The above results are assess the effectiveness of any therapeutic approach. difficult to interpret, since they concern small studies Only randomized trials of adequate size give sufficient on patients differing in terms of age (adults and statistical power to provide information. children), severity of IgAN and, more importantly, degree of proteinuria. In this regard, it is important to Fig. 2 . Evolution of proteinuria levels in the Italian multicentre randomized trial of corticosteroids [9] in the treatment (21 patients) Fig. 1 . Renal survival in the Italian multicentre randomized trial of and control (18 patients) groups of the 5-year cohort. Mean urinary corticosteroids [9] estimated on the basis of reduction in GFR protein excretion significantly decreased in the steroid group (from (estimated using the Cockcroft and Gault formula) to more than 1.93±0.45 g/day at baseline to 0.78±0.41 g/day at 1 year), and this 50% below baseline values (equivalent to the primary endpoint of decrease persisted during the whole follow-up; proteinuria remained 100% increase of plasma creatinine levels from baseline).
unchanged in the control group.
Italian randomized controlled trial of control group for both primary endpoints, i.e. a 50% corticosteroids and 100% increase from baseline plasma creatinine levels. This is seen in 17% and 21% of the patients, respectively; log-rank test P<0.048 and <0.005) Given that IgAN is also the commonest glomerulonephritis in Italy, it is not surprising that we were ( Figure 1 ). Three patients in the control group and none in the steroid group required dialysis. Mean particularly interested in finding an effective and relatively safe therapy. It is well known that tubulo-urinary protein excretion also significantly decreased in the steroid group (from 1.93±0.45 g/day at baseline interstitial scarring is the most important histological factor contributing to progression in any kind of to 0.78±0.41 g/day at 1 year), and this decrease persisted throughout the follow-up, whereas proteinuria nephropathy, including IgAN. Moreover, proteinuria is the main prognostic factor in IgAN and it heavily remained unchanged in the control group ( Figure 2 ).
These results are further supported by the results of contributes to interstitial fibrosis. Considering the importance of proliferative lesions in the acute phase the multivariate Cox analysis, using a 50% increase in baseline plasma creatinine as the endpoint. The analysis of IgAN in conditioning glomerular and tubular sclerosis later on, we decided to choose steroids as first line showed that steroid treatment, female gender and absence of vascular sclerosis were correlated with a therapeutic approach because they decrease proteinuria and possibly limit fibrosis reducing exudative lesions. lower risk of renal dysfunction. When the reduction in proteinuria between baseline and the 6-month followAccording to previous clinical experiences, we performed a multicentre randomized controlled trial in up was added to the Cox model, it was associated with better renal survival and, more interestingly, the beneorder to evaluate the effects of a course of steroid (methylprednisolone 1 g i.v. for three consecutive days ficial effect of steroid treatment disappeared from the final model, thus suggesting that the effect of steroid at the beginning of months 1, 3 and 5, plus oral prednisone 0.5 mg/kg every other day for 6 months) treatment may be mainly due to reduction of proteinuria. This effect was not influenced by the adminisin comparison with supportive therapy. We studied 86 biopsy-proven IgAN patients in the early stage of the tration of ACE-inhibitors, because the percentage of patients treated with these agents was the same in the nephropathy with relatively well preserved renal function and significant proteinuria (1-3.5 g/24 h) [9] . We two groups. Furthermore, by multivariate Cox regression analysis the use of ACE-inhibitors was not signiexcluded patients with heavy proteinuria to avoid the possible confounding effect of minimal change disease ficantly correlated with a better outcome. Only the onset with macrohaematuria, which is a well-known with IgA deposits as mentioned above. Given the high prevalence of this form of glomerulonephritis, it is favourable prognostic factor, was unbalanced between the two groups (more common in the control group). surprising that we were able to enrol only 86 patients from seven participating centres in a period of 8 years. However, as the duration of nephropathy was not different in the two groups, the onset with macroThese difficulties reflect the scepticism in many Italian nephrological centres concerning the effectiveness of haematuria was not a cause of the early detection of IgAN. Even more importantly, the multivariate Cox steroid therapy. Against the background of disappointing results in previous small studies [6] [7] [8] , the regression analysis with the doubling of baseline plasma creatinine as the endpoint found that macroresults of the Italian study are fascinating [9] . After 5 years' follow-up, renal survival was significantly better haematuria at the onset lowered the relative risk of progression also in our trial. This could have favoured in the group with steroid treatment compared with the the control group prognosis and thus possibly reduced randomization led to a severe bias concerning the choice of the patients to be treated (higher risk the magnitude of the observed difference of renal survival between the two groups due to steroids. The patients). Combined treatment with prednisolone for 2 years and cyclophosphamide for 3 months, followed consistency of the results is underlined by the fact that the five patients (four in the control and one in the by azathioprine was also shown to be effective in preserving renal function at 3 years in 37 randomized steroid group), who violated the protocol because they were given steroids as rescue treatment after the devel-adult IgAN patients with moderate rate of CRF progression [11] . In children with newly diagnosed opment of persistent nephrotic syndrome, also had a significant decrease in proteinuria after 6-month steroid IgAN, Yoshikawa and Ito [12] recently reported that treatment with prednisolone, azathioprine, heptreatment (from proteinuria levels of, respectively, 6.8, 5.9, 10.7, 12.5 g/day to 0.3, 2.0, 2.8, 0.4 g/day).
arin-warfarin, and dipyridamole for 2 years was effective in reducing proteinuria (from 1.35±1.01 to It is worth noting that the 6-month steroid course appeared to be relatively safe, since the patients assigned 0.22±0.31 g/24 h), serum IgA levels and the intensity of mesangial IgA deposits (P=0.02), with no change to the steroid group did not experience any major side effects during the follow-up (excepting one patient who in the percentage of sclerotic glomeruli. The relatively short follow-up period (2 years) after an 'early' diadeveloped diabetes mellitus 2 years after treatment).
gnosis did not allow to establish the effect of treatment on renal function deterioration (only one patient in the Are steroids alone enough?
heparin-warfarin and dipyridamole group developed CRF ). Although relatively few serious side effects were reported, in our opinion the 2-year treatment with Although the results of our study [9] very consistently document a positive effect of steroids on the natural azathioprine in children affected by a low-progressive disease rises great concern about long-term adverse course of IgAN, some problems deserve comment. First of all, by multivariate Cox regression analysis the effects, such as the risk of gonadal toxicity and oncogenicity (although the experience on transplanted chileffect of steroids was not greater than that of female gender in protecting against renal function deteriora-dren is reassuring). Considering that the combination of heparin-warfarin and dipyridamole was completely tion (although the positive effect of steroids was the same in both genders). This observation suggests a ineffective, it is surprising that the authors planned a new controlled trial aimed at comparing the effects possible role of genetic factors on the extreme variability of IgAN outcome that seems to be only partly of prednisolone, azathioprine, heparin-warfarin, and dipyridamole with prednisolone alone. modifiable by treatment. On the other hand, although the difference in renal survival was particularly striking
In conclusion, in our opinion the key question is not so much whether prednisolone and azathioprine until the third year, the risk of renal function deterioration was subsequently quite similar in both the treated are essential components of the combined therapy, but whether prednisolone alone is enough to ensure stable and untreated patients. Furthermore, in some patients proteinuria increased again during follow-up. It is remission and if azathioprine can add further benefit.
Only if azathioprine (possibly at a lower dose) has possible that the steroid effect, as well as being different in these patients, may decrease over time.
been proven to provide substantial long-term benefit would we no longer object to use this agent in children. One possibility to circumvent this shortcoming would be to introduce a second course of steroids after This is exactly the reason why we planned a new longterm randomized controlled adequately-sized trial to 2-3 years. Considering that we found a very close relationship between reduction of proteinuria and pre-evaluate the role of low-dose of azathioprine added to steroids in adult patients with IgAN. servation of renal function, urinary protein excretion might be a useful indicator for the necessity to start another course of therapy. However, the results of our References trial [9] suggest that the first 6-month course of therapy is probably not sufficient to ensure stable remission 1 Introduction the thin GBM. In some families, the occurrence of extra-renal symptoms such as deafness (10%) has been Thin glomerular basement membrane (GBM ) is a reported. Electron-microscopy occasionally reveals not frequent biopsy finding, occurring in 5-10% of renal only extreme thinning of the GBM, but also some biopsy series. Biopsies of kidney allografts indicate lamellation. These clinical and pathological features that the frequency of thin GBM may even reach up to resemble those of early Alport syndrome, in which the 9% in the general population [1] , making it the most underlying structural defect of basement membranes is common renal condition.
caused by mutations in type IV collagen genes. Given the similarities to early Alport syndrome, it has long been suspected that thin GBM might be related to Symptoms mutations in the autosomal type IV collagen genes. Type IV collagen is a major structural component Clinically, individuals with thin GBM almost always of all basement membranes, providing a molecular present with microscopic haematuria. The family his-scaffold in the form of a supramolecular network. tory is positive for haematuria in more than half of Six genetically distinct type IV collagen a-chains the cases, while systematic urinalysis reveals haemat-(a1-6(IV )) have been identified, four of which, the uria to be present in more than 90% of the families, so-called novel chains (a3-a6(IV )) have been implicaffecting half of all relatives. Thin GBM therefore ated in the pathogenesis of Alport syndrome. seems to be an autosomal dominant condition with Homozygous mutations in the COL4 genes on chromoregard to haematuria. Other symptoms include macro-some 2 encoding the a3 and the a4 chains cause the scopic haematuria, loin pain and low-degree pro-autosomal form of the disease. While homozygotes teinuria. The clinical course of thin GBM is usually present with the 'classical' symptoms of Alport synbenign with an excellent prognosis, which has led to drome, heterozygote carriers present with microscopic the clinical nomenclature 'benign familial haematuria'. haematuria in >60% of the cases, proteinuria in >10%, and hearing loss in >20%. haematuria in which they found linkage to the COL4A3/A4 gene locus. They also identified a results from immunohistochemical and immunogold studies indicating that the thin GBM contains all COL4A4 mutation which caused the phenotype of benign familial haematuria in heterozygous carriers, the normal type IV collagen chains (a1-5(IV )) [7] .
Possible effects of COL4A4 mutations in benign familthereby establishing for the first time that type IV collagen mutations may indeed represent the molecular ial haematuria could be a decreased content of type IV collagen novel chains in the GBM, a reduced degree basis for thin GBM disorder as well as Alport syndrome.
of cross-linking in the type IV collagen network, and ultimately decreased GBM thickness and stability. The hypothesis that benign familial haematuria represents a carrier status of autosomal Alport syndrome, While the molecular pathogenesis of thin GBM needs more study, we believe that the window for its at least in some cases, is supported by the molecular characterization of other families [4, 5] . In one con-understanding has now been opened, paving the way for improved diagnostic testing in the future. It is sanguineous family, the elimination of a COL4A4 exon from the mRNA was associated with haematuria in hoped that this will eventually facilitate the approach to patients with isolated haematuria for clinicians. heterozygotes, while homozygotes presented with hearing loss and more advanced impairment of renal function, fulfilling the diagnostic criteria of Alport References syndrome [4] . Preliminary results of a recent linkage study of 13 families with biopsy-proven thin GBM 1 circadian profile which determines diabetic complica-tions. This cannot be assessed properly using clinic better reproducibility, complete assessment of the circadian profile and exclusion of the 'white coat phenommeasurements or even self-measurements of blood pressure by the patient. Its evaluation necessitates enon' [6 ] . Sturrock [7] measured 24 h blood pressure in diabetic out-patients and showed that the values of ambulatory blood pressure measurement. This group of Austrian German diabetologists and nephrologists clinic blood pressure were wrong for systolic blood pressure in 82% and for diastolic blood pressure in feel that ambulatory blood pressure measurement is not utilized sufficiently. We marshal some evidence 55% of the patients. Nielsen et al. [8] noted that 'white coat' hypertension was present only in 8 and 9% of which illustrates the relevance of ambulatory blood pressure measurement in diabetic patients, particularly the microalbuminuric and macroalbuminuric diabetic patients studied, whereas this phenomenon was present in diabetic patients with renal disease.
in 23% of normoalbuminuric patients. Equiluz-Bruck et al. [9] examined 72 patients with type 2 diabetes
The value of blood pressure reduction in diabetic and found that an absent nocturnal decrease in blood patients pressure (non-dipping) was more frequent in diabetic compared with non-diabetic hypertensive individuals. In patients with type 2 diabetes, non-dipping, i.e. a Arterial hypertension is a decisive risk factor for the initiation and/or progression of diabetic microangiopa-nocturnal decline of BP <10%, was significantly correlated with the albumin excretion rate. Non-dipping was thy and macroangiopathy. Hypertension is 2-3 times more frequent amongst diabetic compared with non-found in 80% of patients with macroalbuminuria and 74% of patients with microalbuminuria, but only in diabetic individuals. The prevalence of hypertension increases with increasing rates of urinary albumin 43% of patients with normoalbuminuria. The authors argued that non-dipping might contribute to the high excretion [1] . The overriding importance of lowering the blood pressure for the reduction in the rate of cardiovascular mortality of diabetic patients with microalbuminuria or macroalbuminuria. cardiovascular complications in diabetic patients has been documented by several recent studies. In 1996, Recently, Poulsen et al. [10] documented that 24 h blood pressure is correlated with albumin excretion the SHEP study (Systolic Hypertension in the Elderly Program) documented that in elderly patients with rate even in type 1 diabetic patients without diabetic renal disease, i.e. in normoalbuminuric patients. An type 2 diabetes and isolated systolic hypertension, low doses of diuretic treatment compared with placebo attenuated decline in nocturnal blood pressure is apparently an early indication of end-organ damage: Poulsen reduced the rate of cardiovascular events by 34% [2] . The absolute reduction of risk by active treatment et al. found that in such normoalbuminuric patients with type 1 diabetes, higher night time blood pressure compared with placebo was twice as high in diabetic patients compared with non-diabetic patients, i.e. values and failure of blood pressure to decrease during the night were correlated with early appearance of 101/1000 vs 51/1000 randomized patients during a 5-year follow-up. This observation illustrates that the retinopathy [10] . We emphasize that in these patients diabetic nephropathy was excluded because of the absolute risk is markedly higher in diabetic patients. The excess risk of hypertensive diabetic patients normal urinary albumin excretion rate. Non-dipping is also a predictor for the development of microalbumirecently was also confirmed in the HOT (Hypertension Optimal Treatment) study [3] . When a target blood nuria: in a 3-year follow-up study, Poulsen et al. [11] documented that patients with type 1 diabetes who pressure of 80 mmHg was aimed at instead of 90 mmHg, the rate of cardiovascular events and fatalies were non-dippers had a significantly higher risk of developing microalbuminuria than did patients with was halved. This was not demonstrable in the nondiabetic population. A most impressive reduction of normal dipping of blood pressure during the night.
Based on these results, one must conclude that an incidences of death recently could also be demonstrated in the UKPDS ( UK Prospective Diabetes Study) [4, 5] . absent nocturnal decrease in blood pressure is a first important indicator of evolving renal damage. In patients with intensified compared with regular blood pressure lowering, i.e. BP 144/82 mmHg com-Recognition of the risk will allow timely therapeutic intervention [12] . pared with 154/87 mmHg, the risk was markedly lower both for macrovascular and microvascular complicaOf particular interest is the study of Nakano et al. [13] who found a relationship between the circadian tions including renal events. No significant difference could be demonstrated between atenolol and captopril. blood pressure profile and the occurrence of fatal and non-fatal vascular events in patients with type 2 diabetes. The authors followed 325 patients over 3-4.5
Importance of ambulatory blood pressure years. If these diabetic patients had a 'reversed' circameasurement dian blood pressure profile, the risk of dying was 20-fold higher than patients who had a normal decrease in blood pressure during the night (P=0.0001). Of Recent studies clearly indicate that in diabetic patients, measurement of ambulatory 24 h blood pressure is a particular note is the observation that most sudden deaths or strokes occurred during night time or early much better predictor of microvascular and macrovascular complications than conventional blood pressure morning. This observation is in line with the results of the ISIS-2 study [14] which documented that the rate measurement. Such superiority is presumably due to of myocardial infarctions increases dramatically Conclusions between 6 and 8 a.m. For a long time, it had been suspected that genetic predisposition to essential hyper-There is no doubt that 24 h blood pressure measuretension determines the risk of patients with type 1 ment in diabetic patients with renal disease yields diabetes to develop diabetic nephropathy. Using ambu-information which goes far beyond what can be latory blood pressure measurement, Fagerudd et al. obtained with clinic blood pressure measurement or [15] could clearly show that parents of patients with self-measurements. Particularly night time blood prestype 1 diabetes and nephropathy had a significantly sure values permit a much more focused antihypertenshigher prevalence of hypertension than parents of ive treatment in diabetic patients with nephropathy as propositi with type 1 diabetes and without nephro-discussed elsewhere [18] . It is the opinion of the pathy. These studies illustrate the high sensitivity of authors that ambulatory blood pressure measurement ambulatory blood pressure measurements for evaluat-is indispensable for optimizing antihypertensive treating the renal risk. Similar observations have also been ment in diabetic patients with nephropathy. made in type 2 diabetes [16 ] 
were given laxatives before intravenous pyelography, a factor further aggravating dehydration. Observations A decline of renal function after the administration of comparing hydrated patients with a historical populacontrast media (CM ) is a frequent cause of hospital-tion gave the first clues that a fluid load might prevent acquired acute renal failure. This so called contrast-CMIN [2] [3] [4] . So far, no controlled systematic study media-induced nephropathy (CMIN ) includes a has been published addressing the question which sort haemodynamic response to contrast media and tubulo-of fluid, how long, how often and how much should toxicity. Although the clinical features of CMIN have be given in order to minimize the risk of CMIN. been well described, uncertainties concerning the prophylaxis and clinical relevance of this form of nephroExperimental studies toxicity persist. The purpose of this article is to review the role of a hydration strategy in the prevention of In a rabbit model of CMIN involving low-sodium diet this condition.
and administration of indomethacin, the infusion of From a theoretical point of view prehydration of isotonic saline or isotonic mannitol (both given at a patients may have the following beneficial effects on rate of 20 ml/h/kg, equal to 4% of the animal's body the kidney:
weight over a 2-h period) parallel to the infusion of $ decreased activity of the renin-angiotensin system, the contrast media was not able to prevent acute renal $ downregulation of the tubuloglomerular feedback, failure, while pre-treatment of the animal with chronic $ augmentation of diuresis and sodium excretion, high sodium intake and DOCA administration did [5] . $ dilution of the contrast media and thus prevention As plasma renin activity is reduced by administration of renal cortical vasoconstriction, of DOCA as well as by an acute infusion of saline and $ reduced pre-constriction of the vessels, mannitol, the authors concluded that apart from $ avoidance of tubular obstruction, and lowering of intrarenal renin and plasma renin activity, $ reduction of endothelin and other intrarenal vaso-the increase of urinary sodium and solute excretion constrictive mediatiors (e.g. vasopressin).
per se (and probably the plasma volume expansion) contributed to the prevention of CMIN. These data were confirmed by our own study in rats with high intravascular resistance due to chronic NO inhibition. DOCA pre-treatment completely reversed the haemo-
Historical background
dynamic response to contrast media [6 ] . Yoshioka et al. [7] showed that water-deprived rats (72 h) had Approximately 30 years ago several studies docu-reduced activities of catalase and superoxide dismutase mented that dehydration accentuates the risk of renal and were highly sensitive to the application of diatrizofailure especially in patients with diabetes mellitus or ate which caused a significant and persistent fall in pre-existing renal failure [1] . The incidence was higher GFR 72 h after CM application. After injection of in summer at a time when no special hydration was saline water-deprived rats gradually normalized GFR performed and patients had to thirst before excretory by 72 h. urograms in order to maximize the concentration of 
Clinical studies
induced vasoconstriction, partial pressure of oxygen in contrast media damage [8] [9] [10] [11] [12] [13] . The authors found that the medalla could thus be reduced below a critical hydration alone was as effective or even better than point. Consequently, if it is used at all, frusemide additional administration of hypertonic mannitol or should be administered with caution, rigorously the administration of one of the vasodilative agents.
avoiding dehydration, which, by itself, would definitely Other investigators compared results in patients subenhance the nephrotoxicity of contrast agents. mitted to special hydration protocols with historical control groups [2, 3] or data reported in the literature [4, 14, 15] whereby with hydration alone the incidence Conclusion of acute renal failure was lower. So far only one controlled, randomized study compared saline adminis-So far no controlled prospective study addressed the tration alone (0.45% saline over 24 h, starting 12 h issue, which hydration strategy is optimal in order to before administration of radiocontrasts) with mannitol prevent CMIN. Presently, it seems appropriate to start (25 g of mannitol given 60 min before administration hydration at least 12 h before administration of conof radiocontrasts) or frusemide (80 mg i.v.) [8] . In this trast media in order to induce volume expansion with study administration of saline alone was the most concomitant suppression of the renin system. This successful strategy. In numerous studies dealing with could be continued for 12-20 h after the procedure. the nephroprotective effect of non-ionic contrast media The best route of fluid administration, the amount and prehydration of the patients was included in the proto-the type of fluid have to be clarified. Whether this col [16, 17] , but patients with cardiac failure, liver strategy is safe in patients with heart failure, liver cirrhosis or oedema have mostly been excluded from cirrhosis and edema has to be shown in future studies. the studies in order to avoid overhydration.
The use of loop-active diuretics should be avoided as no benefit in preventing CMIN has been proved and hypovolaemia could be enhanced.
Which fluid and when to start? References
Most investigators administer 0.45% saline in combination with 5% dextrose intravenously in various provided evidence for an effect of the VDR polymorphHowever, clinical studies have shown that bone mineral isms on BMD, but it was quantitatively modest [2] . It density (BMD) is under genetic control, probably has also been shown that environmental factors may polygenic in origin, and several candidate genes, influence the effect of genetically determined BMD. namely oestrogen and vitamin D receptors ( VDR), as Thus, VDR genetic polymorphisms have been linked well as collagen type I a 1 among others, may mediate to differences in intestinal fractional calcium absorpimportant differences in bone mass and bone metaboltion. As such, individuals with the bbaaTT haplotype ism. Since the first description by Morrison et al. [1] , showed a higher rate of radiocalcium absorption [3] . several groups have shown that genetic polymorphisms Conversely, individuals with the BB genotype had a at the 3∞-untranslated region of the VDR gene may lower efficiency of calcium absorption after dietary account for at least some of the genetic variation in calcium restriction and had a lower BMD than those bone mass. These polymorphisms are defined by the with the bb genotype [4] . This finding would be consistpresence or absence of a restriction site for the enzymes ent with the presence of functional differences in the BsmI, ApaI and TaqI. Since that initial report, VDR intestinal VDR among different VDR genotypes. gene polymorphisms have been associated with BMD, However, the mean increase of BMD after treatment peak bone density, bone turnover and the serum levels with vitamin D was significantly higher in individuals of some biochemical bone markers, as well as the rate with the BB and Bb genotypes compared with the bb of bone loss, risk of osteoporotic fracture and the genotype [5] . A more pronounced suppression of PTH relative response to several treatments of osteoporosis concentration by calcitriol has also been described in such as vitamin D or calcium.
individuals with the bb genotype. Furthermore, VDR polymorphisms have been associated with urinary calcium excretion, but in this specific study they were not
VDR polymorphisms in patients without renal
related to BMD [6 ] . Consequently, VDR polymorphfailure isms seem to represent one of the genetic factors affecting BMD, but they account only partially for the According to the most widely analysed BsmI restriction overall genetic effect on bone mass and this effect is site-B absence, b presence of a cleavage site-several not observed in all the screened populations. studies have documented that in patients without chronic renal failure (CRF ), the presence of two copies to the development of primary and secondary hyperpa-rathyroid disorders. Whereas the BBAAtt genotype bone loss occurring after renal transplantation, since those exhibiting the B allele had lower BMD from the has usually been related to lower BMD in non-renal populations, an increased prevalence of the poly-third month after grafting. These results are in agreement with those initially presented by Morrison et al. morphic VDR alleles b, a and T has been demonstrated in sporadic primary hyperparathyroidism (HPT ). The [1] in osteoporotic populations, as well as some preliminary data described in orthotopic hepatic transplanta-VDR haplotype baT seems to be a risk factor for parathyroid adenomas, possibly by interfering with the tion (Guardiola et al., unpublished data). Therefore, it seems likely that the effect of the VDR genotype on inhibitory action of calcitriol [7, 8] . Thus, in patients who were homozygotous the baT alleles parathyroid BMD may become more evident under challenging conditions (such as calcium restriction or following tumours exhibited lower VDR mRNA and higher parathyroid hormone (PTH ) mRNA levels than those corticosteroid treatment). Nevertheless, in CRF patients, there are so many interrelated confounding harbouring the BB, AA or tt genotypes [7] . In contrast, the BAt haplotype has recently been shown to be variables, affecting both bone and parathyroid gland function, that the relative effect of a specific genetic under-represented in primary HPT but is related to larger parathyroid lesions, as well as a less deranged background may be easily masked by other environmental or physiopathological factors with a stronger calcium sensor protein expression and parathyroid cell function. In these patients, primary HPT may be direct influence on those tissues. As a result, it seems clear that VDR polymorphisms are not one of the associated with genetic determinants, which may act mainly by altering the regulation of cell proliferation, main determinants of BMD in patients undergoing dialysis, although it may affect bone mass in some rather than the calcium-sensing mechanism of the parathyroid cells [8] .
subgroups of patients or in certain populations. However, data correlating VDR polymorphisms with secondary HPT and renal bone disease are sparse.
Physiological consequences of VDR
Higher PTH levels in individuals with the bb genotype polymorphisms and lower PTH levels in the BB genotype have been reported in patients undergoing dialysis [9, 10] . In a large haemodialysis population, Tsukamoto et al. [9] It is worth mentioning that the previously stated restriction enzymes act in an untranslated region of found that the bb genotype correlated with higher PTH levels than did the BB genotype. This finding has been the DNA, and so none of the restrictive polymorphisms change the translated protein. Consequently, it is confirmed by others. In addition, Fernandez et al. [10] have independently described the presence of a higher difficult to establish a link between the presence of the different alleles and differences in VDR expression or frequency of the BB genotype and the B allele in their low PTH group. Both PTH and osteocalcin levels have functionality. It was previously thought that the b allele was linked to a decreased transcriptional activity also been reported to be higher in the aa and bb genotype, and preliminary data showed that the aa or VDR mRNA stability, and that such reduction of VDR expression in the parathyroids of 'bb' patients genotype may be linked to an acute higher PTH increase when serum calcium was lowered during dia-could lead to decreased vitamin D action (calcitriol resistance) and contribute to parathyroid cell proliferalysis. However, many other groups have been unable to relate the VDR genotype with the severity of tion. On the contrary, it was possible that the B allele could be associated with an increased VDR mRNA secondary HPT, VDR mRNA levels or the pattern of renal osteodystrophy. All these inconsistencies, and the expression or stability. Although the baT alleles have been shown to be linked to lower VDR and higher poor reproducibility of results among different populations (either with or without CRF ), may be caused by PTH mRNA levels in primary HPT [7] , VDR polymorphisms do not seem to affect the abundance of the sampling bias, ethnicity (the prevalence of the suspected high-risk genotypes is very low in some popula-VDR mRNA in other studies and recent data do not confirm allele-specific differences in mRNA [12, 13] . As tions and this factor would limit the statistical power of analysis), confounding environmental and dietary a consequence, the mechanistic association between VDR polymorphisms and their phenotypic coninfluences, age, obesity, physical activity, sex, menopausal status or other yet unidentified factors.
sequences is not yet clear. A recently described polymorphism at the first of the two potential translation initiation sites (ATG) in the promoter region of the
VDR polymorphisms in renal transplantation
VDR gene (defined as starting codon polymorphism by the FokI restriction enzyme) may provide more helpful information [14] . The T/C polymorphism The genetic expression of VDR alleles has also been studied in renal transplant patients to analyse whether defines two distinct VDR protein lengths with apparently distinct affinity for its ligand and therefore differthese alleles may predict post-transplant loss of bone mass [11] . In this context, the bb genotype was linked ent biological activity. However, only preliminary and inconsistent information is currently available on FokI to a better rate of bone recovery between 3 and 12 months after grafting, independent of the prevailing polymorphisms in patients with CRF. Moreover, inheritance of bone mass is probably under polygenic con-PTH levels [11] . Thus, patients with the bb genotype are, to some extent, protected against the common trol and a linkage disequilibrium effect between the 1995; 10: in the quantity, properties or cellular responsiveness [978] [979] [980] [981] [982] [983] [984] to calcitriol have been found, which significantly correl- 
Introduction
Usually the graft is manufactured from polytetrafluoroethylene (PTFE). In some populations in the United It is clear to most clinicians and even recognized by States PTFE dialysis grafts account for as many as the NKF-DOQI task force that the primary choice of 83% of access placements [1] . The European Dialysis vascular access is an arteriovenous fistula (AVF ), and Transplantation Association ( EDTA) does not typically connecting the radial artery with the cephalic collect data on this issue. A survey on 1 January 1997, vein system [1] . However, many patients depend on which included the majority of the approximately 3000 haemodialysis patients of The Netherlands found that Correspondence and offprint requests to: Peter J. Blankestijn, 30% of this population was dialysed using a graft, Department of Nephrology, Room F03.226, University Hospital, PO Box 85500, 3508 GA Utrecht, The Netherlands. mostly PTFE grafts.
by the anatomy of the supplying artery, the graft and in clinical practice which may help to reduce thromthe draining venous system. Both flow and pressure bosis rate of PTFE grafts.
can be used as an index of resistance. Venous pressure measured by the dialyser increases
Identifying grafts at risk of thrombosis
when resistance increases due to the presence of a stenosis. It is important to realize that only the resistFully matured native AVFs seldom clot. In contrast, ance of the flow tract downstream from the venous graft thrombosis occurs at a rate of 0.5-1.3 events per needle will be reflected by venous pressure. Most patient year [1] [2] [3] [4] . A substantial number of studies stenoses are located at the venous anastomosis or have indicated that thrombosis is associated with the elsewhere in the venous outflow tract [5] [6] [7] [8] [9] . Indeed, presence of one or more stenotic areas, which are, in Schwab et al. [12] and Besarab et al. [13] showed in the majority of cases, located at the venous anastomosis their landmark papers that venous pressure is an easily or elsewhere in the venous outflow tract [5] [6] [7] [8] [9] . It is applicable method to select patients at risk of thromnow clear that timely treatment of these stenoses before bosis. They showed that treating stenoses in patients thrombosis occurs, reduces the thrombosis rate.
identified in this way indeed resulted in a reduction of thrombosis rate to approximately 0.20 per patient year. This very low number needs to be looked at with some
Physical examination
caution, because the data included native AVFs which have a spontaneous thrombosis rate that is much lower A number of findings may indicate the presence of than in AV grafts. Cayco et al. used venous pressures venous stenosis. These include: oedema of the extremity for surveillance of grafts [3] . They reported a thromwhere the vascular access is located, prolonged bleeding bosis rate of 0.29 events per year. Thus, it seems safe after venipuncture, and changes in pulse or thrill in to conclude that venous pressures are helpful in the the graft [10] . Only few studies have systematically effort to reduce thrombosis rate. assessed the value of physical examination. Especially auscultation and palpation of the graft have turned out to be helpful in localizing stenotic lesions in some Access flow studies [7] [8] [9] [10] . Although physical examination is simple and inexpensive, many clinicians will feel that High resistance will lead to low flow. Older studies its value is limited because results are highly investig-showed that low graft blood flow is associated with an ator dependent.
increased risk of thrombosis (summarized in [14] ). However, the earlier techniques used to measure flow are unsuitable for routine use in clinical practice.
Imaging techniques
Recent technological developments have allowed the introduction of an interesting and potentially valuable Because of the strong association between thrombosis new tool. Krivitski [15] showed that flow can be and the presence of stenosis, some have advocated measured relatively easily in grafts by an ultrasound screening patients for stenoses, in order to be able to dilution technique ( Transonic HD01 Hemodialysis treat these anatomical abnormalities before they cause Monitor; Transonic Systems, Inc., Ithaca, NY ). We thrombosis. Angiography and magnetic resonance and others have provided evidence that this new techimaging provide information concerning the anatomy nique indeed enables us to quantify graft flow with but are unsuitable for routine screening. Doppler ultra-sufficient accuracy [14, 16, 17] . Graft flow ranges from sonography has been used and found reasonably <100 ml/min to >2000 ml/min. We found in 166 effective for localizing stenoses. The concept that cor-grafts four cases with flows >2000 ml/min [14, 18, 19] , rection of asymptomatic stenoses would improve whereas May et al.
[8] reported a flow >2000 ml/min patency, was recently tested. Lumsden et al. random-in nine of 87 PTFE grafts. ized patients with >50% stenosis to have either a
In a subsequent study we confirmed that patients percutaneous transluminal angioplasty (PTA) or no with stenoses in the venous outflow tract show on PTA [11] and found that outcome did not differ in the average a higher venous pressure and lower flow than two groups. These negative results are important. The those without stenosis [18] . However, venous pressure authors clearly showed that selection of patients for did not correlate with graft flow. In other words not angioplasty exclusively on the basis of anatomical all patients with high venous pressure had low flow, criteria does not result in a reduction of thrombosis indicating that not all patients who are at risk of rate.
thrombosis can be identified by venous pressure measurements. We also showed that inflow resistance (that
Venous pressures
is resistance of the flow tract upstream of the venous needle) comprises a substantial and very variable part Information on the functional status of the graft can of total graft resistance. This inflow resistance is not reflected by venous pressure measurements. be obtained from flow and pressure. Obviously, grafts
In our next study we investigated the hypothesis did not predict thrombosis. Sands et al. [22] found that patients with PTFE grafts and flow rates that in clinical practice flow measurements indeed give additional information to venous pressures [19] . In a <800 ml/min had a 93% incidence of thrombosis during the 6 months following the measurements. group of patients who were controlled and selected for further diagnostic and therapeutic interventions by These data seem to support the idea that by decreasing the frequency of flow assessment the cut-off value venous pressures, thrombosis still occurred and did so in patients who had a flow <600 ml/min.
indicating increased risk of thrombosis increases. This points to another deficiency in our knowledge. Thus, we have the theoretical basis for the assumption that flow measurements are better than the only Basically, there are no data on the natural history of stenosis development and therefore on the change over validated method for access surveillance, i.e. venous pressure measurements. We have to realize that surveil-time of risk of thrombosis. It seems likely that the absolute value of flow is related to the risk of thromlance using venous pressures is without extra cost and results are very easy to obtain. Therefore, the question bosis, whereas the decrease in flow over time reflects development of stenosis. Factors that influence the is whether flow measurements really confer additional benefit in patients who are monitored using venous speed of development of stenosis are hardly known. It is conceivable that patients with high but decreasing pressure measurements. In other words, when simple clinical variables such as venous pressures are used, is flow need to be evaluated more frequently than patients with stable flow. In a recent study it was shown that there any additional benefit when periodic flow measurements are added to the surveillance protocol? Such especially a decrease in flow over time was predictive of imminent thrombosis [23] . data are not currently available.
Introduction of periodic flow measurements means There are now several devices that claim to provide accurate access flow measurements. Apart from the more work for the dialysis staff and the need for a separate device. It is likely that more interventions, best validated device, i.e. the ultrasound dilution technique introduced by Krivitski ( Transonic Hemodialysis mainly angiographies and PTAs, will be done when flow measurements are added to venous pressure meas-Monitor, Transonic Systems Incorporated), a haematocrit dilution technique (Crit-Line Monitor, InLine urements. This increases cost. PTA means substantial vascular injury and it is possible that frequent PTA of Diagnostics) and a differential conductivity technique (Hemodynamic Monitor, Gambro) [24, 25] are also stenoses enhances the speed of restenosis. However, Beathard [20] found similar results after the first, available. The methods involve indicator dilution or conductivity tracer techniques. An indicator dilution second, or third PTA. Uncontrolled and retrospective comparisons of the results of PTA of stenoses of technique detects recirculation by the dilution of arterial blood caused by a bolus of normal saline injected thrombosed grafts versus those of non-thrombosed grafts suggest that outcome of the latter is somewhat into the venous blood line; a conductivity tracer technique involves measurement of differential conductivity better (reviewed in [21] ). These studies suggest that outcome of treatment of less severe stenosis (not lead-between arterial and venous blood flows after a bolus of hypertonic saline is injected into venous line as the ing to thrombosis) is better than that of the more severe stenosis. Furthermore, studies suggest that sec-conductivity 'tracer'. Both techniques are used while the patients dialysis blood lines are temporarily ondary patency increases with access surveillance, repeated angiography, and stenosis correction as com-reversed to induce recirculation. From the measured recirculation and the knowledge of the dialyser blood pared to an 'act only if thrombosed' approach [12, 13] . Additionally, it is possible that overall morbidity and flow rate, access blood flow can be calculated. Recently it was shown when compared to the ultrasound dilution even mortality decreases. An elective treatment of stenosis is a less complicated procedure than throm-technique that the technique based on differential conductivity measurements give virtually identical bolysis combined with PTA. Furthermore, treatment of thrombosed grafts frequently necessitates placement results for access flow, and that the Crit-Line device overestimates flow [24] . of an intravenous catheter. Placement and use of these catheters is associated with considerable morbidity. All these issues need to be taken into account when Recirculation balancing the cost-effectiveness of the introduction of periodic flow measurements.
Several other issues concerning flow measurements Access recirculation is defined as the return of dialysed blood to the arterial segment of the access bypassing are still unclear. The optimal frequency of measurements and the optimal threshold level for intervention the systemic circulation. This method was recently reviewed by Schneditz [26 ] . When compared with a have not been determined. We found in a group of patients monitored by venous pressures that almost all method using a non-urea indicator, it became clear that in most cases values of >10% mean true access thromboses that still occurred did so in patients with a flow <600 ml/min measured within the 2 months recirculation in most cases [27] .
From a theoretical point of view it seems that prior to thrombosis [19] . May et al. [8] reported that relative risk of thrombosis within 3 months after recirculation occurs only when spontaneous graft flow approaches the level of dialyser blood flow, because in measurements was 1.36, 1.51 and 1.67 when flow was 850, 750 and 650 ml/min respectively. Venous pressure all other cases dialysed blood will not be allowed to 7. Safa AA, Valji K, Roberts AC, Ziegler TW, Hye RJ, Oglevie be taken up again by the arterial line of the extracor-SB. Detection and treatment of dysfunctional hemodialysis poreal circuit. Indeed, a recent study has indicated that access grafts: effect of a surveillance program on graft patency recirculation is absent unless access blood flow is and the incidence of thrombosis. 
Introduction
immunoassay ( EIA) and may routinely provide a quantitative estimation of the genomic burden. Hepatitis C virus ( HCV ) infection is highly prevalent
In some HD patients [1] we observed the same among patients on chronic haemodialysis (HD). This pattern of HCV acquisition: there was an initial viraevidence was accumulated in early 1990s with an emic phase associated with an increase in alanine enormous body of data based on anti-HCV testing. transaminase (ALT ) activity which preceded the antiHowever, anti-HCV assays have failed to unequivoc-HCV seroconversion. This is followed by HCV RNA ally identify a protective antibody or an immune clearance and ALT normalization. Anti-HCV antibody pattern. Furthermore, a large population of anti-HCVappeared 1-2 months after the ALT increase. This positive patients do not show HCV viraemia.
pattern is compatible with a direct cytopathic effect of The use of novel techniques for detecting viraemia the virus; however, other explanations are equally and strains of HCV among HD patients has given us plausible. A mild and short elevation in liver enzymes the opportunity to deepen our understanding of the has been also observed about the time of HBsAg virological and clinical features of HCV in HD. In acquisition in chronic HD patients [3] . The peak of fact, HD patients are a high-risk group for HCV;
ALT during the initial phase of the HCV infection was however, the immune compromise conferred from not high (up to 74 IU/l ); in a previous survey [4] some chronic uraemia may affect the biological properties of the patients with de novo seroconversion for antiof HCV in this population.
HCV showed higher ALT levels (up to 341 IU/l ). In this article, we report some recent advances in However, baseline values of aminotransferase activity the biology of HCV in HD. HCV is an important are typically depressed in chronic HD patients [5] [6] [7] . agent of liver disease in chronic HD patients; the This pattern of acquisition of HCV supports recent clinical implications of these new acquisitions may observations [7] that the relationship between detecthave an impact on the routine clinical activity of able HCV RNA and raised aminotransferase values in nephrologists within HD units.
serum is stronger than has so far been recognized, even if this may be masked by low AST and ALT baseline values. These results strongly confirm a prior recom- solid support where they may react with antibodies in is probably low as the viral load in this population is reduced and stable over time. Various patterns of the patient's serum. Antibodies to these specific HCV peptides bind to the RIBA@ strip to create a dark viraemia in HCV-infected patients on HD exist: repeated testing for HCV RNA is necessary to accurband at the site of the IgG antibody-antigen complex. The reactivity present in the RIBA@ strip is interpreted ately assess viraemia in this population. The HCV types in HD may be easily recognized by serological for assessment of HCV serotypes according to the algorithm reported elsewhere [25] . We used RIBA@ analysis. Chronic uraemia interferes with immunocompetence and this hampers serological response in a HCV serotyping SIA to assess HCV types in a large population of HCV-infected dialysis patients and a significant number of chronic HD patients with HCV. comparison with RT-PCR was made [26 ] RIBA@ HCV serotyping SIA was unable to detect any HCV reactivity in a subset (25%) of HD patients successfully genotyped [26 ] . The limited immunocom-References petence conferred by chronic uraemia prevented antibody production in these individuals.

